NRG-BN013 now open at St Luke’s Radiation Oncology Network.
Well done to Dr David Fitzpatrick (PI), Dr Paul Kelly (NLI), and all site staff involved 👏
With thanks to #IRROG and @nrgonc.bsky.social
Learn more: cancertrials.ie/cti-trials/n... #CancerTrials
Fantastic presentation from @aclaytonlea.bsky.social at the #IRROG Annual Conference on how next-generation cancer trials are improving efficiency and delivering real benefits for patients.
Congrats to #IRROG on a great conference!
#CancerTrials #Radiotherapy #Innovation
Cancer Trials Ireland Vice-Clinical Lead, @gerryhanna.bsky.social @tcddublin.bsky.social presenting on ‘The Future of Radiation Oncology Research’.
A wide-ranging presentation covering many critical topics in cancer research, including biomarkers, AI workflows, and radiomics.
#IRROG #CancerTrials
Speaking this morning at the #IRROG conference in Dublin, Prof Sinead Brennan reflects on the strong and productive relationship between IRROG & Cancer Trials Ireland, providing trial opportunities for patients in 🇮🇪
@gerryhanna.bsky.social @seamusoreilly.bsky.social @aclaytonlea.bsky.social
Chair of our Head & Neck DSSG, Prof Sinead Brennan, recently spoke to the Irish Examiner about the impact of head and neck cancers in 🇮🇪 and the need for continued focus on research and prevention.
📰 Read the article: www.irishexaminer.com/lifestyle/he...
#HeadAndNeckCancerAwareness #IRROG
👏 First patient enrolled at St Luke’s Hospital to the NRG GU012 SAMURAI trial for metastatic renal cancer!
Trial also open at Beacon Hospital.
Exploring if adding radiation to immune therapy improves outcomes. Led in Ireland by Prof Mihai (Beacon) & Prof Thirion (SLRON). In association with #IRROG